Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Current Medicinal Herbal Advances in the Management of Diabetic Neuropathy

Author(s): Neeru Singh*, Kulsoom Hamid, Neha Chauhan, Rupesh Kumar Pandey and Lubhan Singh

Volume 11, Issue 1, 2025

Published on: 05 October, 2023

Page: [1 - 11] Pages: 11

DOI: 10.2174/0122150838252589230925112544

Price: $65

Abstract

One of the most common long-term complications of diabetes is a condition known as diabetic neuropathy. Chronic neuropathic pain is an important and debilitating disease that poses a huge healthcare challenge. Pathogenesis includes abnormalities in the blood arteries supplying the peripheral neurons, metabolic diseases such as myo-inositol depletion, and enhanced nonenzymatic glycation, among other things. Several metabolic processes are triggered when neurons are under oxidative stress, and free radicals are generated. Conventional treatments for neuropathic pain are ineffective despite the abundance of medications on the market today. The use of herbal-based natural medicines to treat hyperglycemia and its accompanying consequences is being studied extensively in addition to the commercially available formulations already on the market. Now that herbal formulations are becoming more common, researchers are paying more attention to them in medication discovery. Therefore, we conducted a comprehensive assessment of herbal medicines and plants that have been shown to have a protective effect on neuropathic pain. Here, the therapeutic effects of each plant have been documented in several neuropathic pain models in animals and humans. Furthermore, the various mechanisms for the protective effects are examined. This review's goal is to summarise the current research on herbal-based therapy for diabetic neuropathy, including pure chemicals derived from plant materials, plant extracts, and Ayurvedic formulations.

Keywords: Neuropathic pain, diabetes, selaginella, oxidative stress, polyol pathway, plant extracts, diabetic neuropathy.

Graphical Abstract

[1]
Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep 2019; 19(10): 86.
[http://dx.doi.org/10.1007/s11892-019-1212-8] [PMID: 31456118]
[2]
Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers 2019; 5(1): 41.
[http://dx.doi.org/10.1038/s41572-019-0092-1] [PMID: 31197153]
[3]
Richner M, Ferreira N, Dudele A, Jensen TS, Vaegter CB, Gonçalves NP. Functional and structural changes of the blood-nerve-barrier in diabetic neuropathy. Front Neurosci 2019; 12: 1038.
[http://dx.doi.org/10.3389/fnins.2018.01038] [PMID: 30692907]
[4]
Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic microvascular disease: An endocrine society scientific statement. J Clin Endocrinol Metab 2017; 102(12): 4343-410.
[http://dx.doi.org/10.1210/jc.2017-01922] [PMID: 29126250]
[5]
Li R, Li D, Zhang H, Wang J, Li X, Xiao J. Growth factors-based therapeutic strategies and their underlying signaling mechanisms for peripheral nerve regeneration. Acta Pharmacol Sin 2020; 41(10): 1289-300.
[http://dx.doi.org/10.1038/s41401-019-0338-1] [PMID: 32123299]
[6]
Zhang J, Zhang B, Zhang J, Lin W, Zhang S. Magnesium promotes the regeneration of the peripheral nerve. Front Cell Dev Biol 2021; 9: 717854.
[http://dx.doi.org/10.3389/fcell.2021.717854] [PMID: 34458271]
[7]
Nascimento OJ, Camila CB, Cavalcanti EB. Diabetic neuropathy. Rev Dor 2016; 17(1): 46-51.
[8]
Yang H, Sloan G, Ye Y, et al. New perspective in diabetic neuropathy: From the periphery to the brain, a call for early detection, and precision medicine. Front Endocrinol 2020; 10: 929.
[http://dx.doi.org/10.3389/fendo.2019.00929] [PMID: 32010062]
[9]
Finnerup NB, Kuner R, Jensen TS. Neuropathic Pain: From mechanisms to treatment. Physiol Rev 2021; 101(1): 259-301.
[http://dx.doi.org/10.1152/physrev.00045.2019] [PMID: 32584191]
[10]
Abraham MM. Diabetic Peripheral Neuropathy Sudan SHH. Rijeka: IntechOpen 2022.
[11]
Kumari R, Bist R. Molecular basis of neurodegeneration and therapies in diabetic neuropathy. Curr Res Diabetes Obes J 2021; 15(2): 555909.
[12]
Najmi A, Javed SA, Al Bratty M, Alhazmi HA. Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents. Molecules 2022; 27(2): 349.
[http://dx.doi.org/10.3390/molecules27020349] [PMID: 35056662]
[13]
Koparde AA. Natural Products in Drug Discovery. In: Doijad RC, Ed. Rijeka: IntechOpen 2019.
[http://dx.doi.org/10.5772/intechopen.82860]
[14]
Mathur S, Hoskins C. Drug development: Lessons from nature. Biomed Rep 2017; 6(6): 612-4.
[http://dx.doi.org/10.3892/br.2017.909] [PMID: 28584631]
[15]
Ahmad S, Zahiruddin S, Parveen B, et al. Indian medicinal plants and formulations and their potential against covid-19–preclinical and clinical research. Front Pharmacol 2021; 11: 578970.
[http://dx.doi.org/10.3389/fphar.2020.578970] [PMID: 33737875]
[16]
Patel M, Kumar R, Kishor K, Mlsna T, Pittman CU Jr, Mohan D. Pharmaceuticals of emerging concern in aquatic systems: Chemistry, occurrence, effects, and removal methods. Chem Rev 2019; 119(6): 3510-673.
[http://dx.doi.org/10.1021/acs.chemrev.8b00299] [PMID: 30830758]
[17]
Saxena S, Bhardwaj AK, Kumar V, Patel MK, Kumar R, Chaurasia OP. Sustainable utilization of medicinal plants of ladakh and lahaul-spiti of trans-himalaya. Def Life Sci J 2018; 3(2): 120.
[http://dx.doi.org/10.14429/dlsj.3.12566]
[18]
Ozioma EJ. Herbal Medicines in African Traditional Medicine In: Herbal Medicine. intechopen 2019.
[19]
Msomi NZ. Herbal Medicine. IntechOpen 2018.
[20]
Bailey CJ. Metformin: Historical overview. Diabetologia 2017; 60(9): 1566-76.
[http://dx.doi.org/10.1007/s00125-017-4318-z] [PMID: 28776081]
[21]
Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal Therapies for Type 2 Diabetes Mellitus: Chemistry. Biology, and Potential Application of Selected Plants and Compounds Cho WC 2013; p. 378657.
[22]
Baker C, Retzik-Stahr C, Singh V, Plomondon R, Anderson V, Rasouli N. Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab 2021; 12.
[http://dx.doi.org/10.1177/2042018820980225] [PMID: 33489086]
[23]
Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3(1): 17002.
[http://dx.doi.org/10.1038/nrdp.2017.2] [PMID: 28205574]
[24]
Forouzanfar F, Hosseinzadeh H. Medicinal herbs in the treatment of neuropathic pain: A review. Iran J Basic Med Sci 2018; 21(4): 347-58.
[PMID: 29796216]
[25]
della Rocca G, Gamba D. Chronic pain in dogs and cats: Is there place for dietary intervention with micro-palmitoylethanolamide? Animals 2021; 11(4): 952.
[http://dx.doi.org/10.3390/ani11040952] [PMID: 33805489]
[26]
Lee J, Jo DG, Park D, Chung HY, Mattson MP. Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: Focus on the nervous system. Pharmacol Rev 2014; 66(3): 815-68.
[http://dx.doi.org/10.1124/pr.113.007757] [PMID: 24958636]
[27]
Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. Int J Cell Biol 2010; 2010: 214074.
[28]
Cell-autonomous. (cell-Intrinsic) stress responses BT-damage-associated molecular patterns in human diseases. In: Injury-Induced Innate Immune Responses. Cham: Springer International Publishing 2018; Vol. 1: pp. 377-426.
[29]
Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: Physiopathology and treatment. World J Diabetes 2015; 6(3): 432-44.
[http://dx.doi.org/10.4239/wjd.v6.i3.432] [PMID: 25897354]
[30]
Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol 2021; 17(7): 400-20.
[http://dx.doi.org/10.1038/s41574-021-00496-z] [PMID: 34050323]
[31]
Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: Diagnosis and management. Neuroendocrinology 2013; 98(4): 267-80.
[http://dx.doi.org/10.1159/000358728] [PMID: 24458095]
[32]
Pop-Busui R, Boulton AJM, Feldman EL, et al. Diabetic neuropathy: A position statement by the american diabetes association. Diabetes Care 2017; 40(1): 136-54.
[http://dx.doi.org/10.2337/dc16-2042] [PMID: 27999003]
[33]
Thakkar RS, Del Grande F, Thawait GK, Andreisek G, Carrino JA, Chhabra A. Spectrum of high-resolution MRI findings in diabetic neuropathy. AJR Am J Roentgenol 2012; 199(2): 407-12.
[http://dx.doi.org/10.2214/AJR.11.7893] [PMID: 22826404]
[34]
Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress: Therapeutic perspectives. Oxid Med Cell Longev 2013; 2013: 168039.
[PMID: 23738033] [http://dx.doi.org/10.1155/2013/168039]
[35]
Al-Taie A, Elseidy A, Victoria A, Hafeez A, Ahmad S. Diabetic microvascular complications and proposed interventions and approaches of management for patient care. Biomed Biotechnol Res J 2021; 5(4): 380-8.
[http://dx.doi.org/10.4103/bbrj.bbrj_153_21]
[36]
Pang L, Lian X, Liu H, et al. Understanding diabetic neuropathy: Focus on oxidative stress. Oxid Med Cell Longev 2020; 2020: 1-13.
[http://dx.doi.org/10.1155/2020/9524635] [PMID: 32832011]
[37]
Bayram EH. Diabetic Neuropathy and Treatment Strategy – New Challenges and Applications. Rijeka: IntechOpen 2016.
[38]
Kooti W, Farokhipour M, Asadzadeh Z, Ashtary-Larky D, Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: A systematic review. Electron Physician 2016; 8(1): 1832-42.
[http://dx.doi.org/10.19082/1832] [PMID: 26955456]
[39]
Wasana KGP, Attanayake AP, Jayatilaka KAPW, Weerarathna TP. Antidiabetic activity of widely used medicinal plants in the Sri Lankan Traditional Healthcare System: New insight to medicinal flora in Sri Lanka. Evid Based Complement Alternat Med 2021; 6644004
[PMID: 33628307] [http://dx.doi.org/10.1155/2021/6644004]
[40]
Dodda D, Ciddi V. Plants used in the management of diabetic complications. Indian J Pharm Sci 2014; 76(2): 97-106.
[PMID: 24843182]
[41]
Khan MS, Aziz S, Khan MZ, et al. Antihyperglycemic effect and phytochemical investigation of Rubia cordifolia (Indian Madder) leaves extract. Open Chem 2021; 19(1): 586-99.
[http://dx.doi.org/10.1515/chem-2021-0053]
[42]
Kaur G, Jaggi AS, Singh N. Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in rats. J Brachial Plex Peripher Nerve Inj 2010; 5: 3.
[PMID: 20181005]
[43]
Kaur G, Bali A, Singh N, Jaggi AS. Ameliorative potential of Ocimum sanctum in chronic constriction injury-induced neuropathic pain in rats. An Acad Bras Cienc 2015; 87(1): 417-29.
[http://dx.doi.org/10.1590/0001-3765201520130008] [PMID: 25673470]
[44]
Hrd F, Wmssk K, Peiris A, Ldam A. A review on the therapeutic potentials of Ocimum sanctum Linn: In the management of diabetes mellitus (madhumeha). J Pharmacogn Phytochem 2015; 4(3): 47-52.
[45]
Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: An evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med 2011; 11(1): 24.
[http://dx.doi.org/10.1186/1472-6882-11-24] [PMID: 21426568]
[46]
Muthuraman A, Singh N. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. J Ethnopharmacol 2012; 142(3): 723-31.
[http://dx.doi.org/10.1016/j.jep.2012.05.049] [PMID: 22706151]
[47]
Comelli F, Bettoni I, Colleoni M, Giagnoni G, Costa B. Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytother Res 2009; 23(12): 1678-84.
[http://dx.doi.org/10.1002/ptr.2806] [PMID: 19441010]
[48]
Wallace MS, Marcotte TD, Umlauf A, Gouaux B, Atkinson JH. Efficacy of inhaled cannabis on painful diabetic neuropathy. J Pain 2015; 16(7): 616-27.
[http://dx.doi.org/10.1016/j.jpain.2015.03.008] [PMID: 25843054]
[49]
Arora A, Taliyan R, Sharma P. Ameliorative potential of cannabis sativa extract on diabetes induced neuropathic pain in rats. IJPSR 2010; 01: 91-9.
[50]
Joseph B, Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis 2013; 3(2): 93-102.
[http://dx.doi.org/10.1016/S2222-1808(13)60052-3]
[51]
Liu Z, Gong J, Huang W, Lu F, Dong H. The Effect of Momordica charantia in the Treatment of Diabetes Mellitus: A Review. Evid Based Complement Alternat Med 2021; 2021: 1-14.
[http://dx.doi.org/10.1155/2021/3796265] [PMID: 33510802]
[52]
Thaifa MS, Roshna N, Arya US, Babu AG. A review on diabetes mellitus and diabetic neuropathy: A plant based approach. J Pharmacogn Phytochem 2017; 6(3): 506-10.
[53]
Kanter M. Effects of Nigella sativa and its major constituent, thymoquinone on sciatic nerves in experimental diabetic neuropathy. Neurochem Res 2008; 33(1): 87-96.
[http://dx.doi.org/10.1007/s11064-007-9419-5] [PMID: 17713854]
[54]
Alkhalaf MI, Hussein RH, Hamza A. Green synthesis of silver nanoparticles by Nigella sativa extract alleviates diabetic neuropathy through anti-inflammatory and antioxidant effects. Saudi J Biol Sci 2020; 27(9): 2410-9.
[http://dx.doi.org/10.1016/j.sjbs.2020.05.005] [PMID: 32884424]
[55]
Yang R, Li L, Yuan H, et al. Quercetin relieved diabetic neuropathic pain by inhibiting upregulated P2X 4 receptor in dorsal root ganglia. J Cell Physiol 2019; 234(3): 2756-64.
[http://dx.doi.org/10.1002/jcp.27091] [PMID: 30145789]
[56]
Xie J, Song W, Liang X, et al. Protective effect of quercetin on streptozotocin-induced diabetic peripheral neuropathy rats through modulating gut microbiota and reactive oxygen species level. Biomed Pharmacother 2020; 127: 110147.
[http://dx.doi.org/10.1016/j.biopha.2020.110147] [PMID: 32559841]
[57]
Zhao B, Zhang Q, Liang X, Xie J, Sun Q. Quercetin reduces inflammation in a rat model of diabetic peripheral neuropathy by regulating the TLR4/MyD88/NF-κB signalling pathway. Eur J Pharmacol 2021; 912: 174607.
[http://dx.doi.org/10.1016/j.ejphar.2021.174607] [PMID: 34743981]
[58]
Zhang Q, Song W, Zhao B, et al. Quercetin attenuates diabetic peripheral neuropathy by correcting mitochondrial abnormality via activation of ampk/pgc-1α pathway in vivo and in vitro. Front Neurosci 2021; 15: 636172.
[http://dx.doi.org/10.3389/fnins.2021.636172]
[59]
Ganesan D, Holkar A, Albert A, Paul E, Mariakuttikan J, Sadasivam Selvam G. Combination of ramipril and rutin alleviate alloxan induced diabetic nephropathy targeting multiple stress pathways in vivo. Biomed Pharmacother 2018; 108: 1338-46.
[http://dx.doi.org/10.1016/j.biopha.2018.09.142] [PMID: 30372836]
[60]
Yang M, Kan L, Wu L, Zhu Y, Wang Q. Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism. Exp Ther Med 2019; 17(3): 2071-6.
[http://dx.doi.org/10.3892/etm.2019.7181] [PMID: 30867693]
[61]
Yan Y, Zhou X, Guo K, Zhou F, Yang H. Use of chlorogenic acid against diabetes mellitus and its complications. J Immunol Res 2020; 2020: 1-6.
[http://dx.doi.org/10.1155/2020/9680508] [PMID: 32566690]
[62]
Sun W, Liu X, Zhang H, et al. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1. Free Radic Biol Med 2017; 108: 840-57.
[http://dx.doi.org/10.1016/j.freeradbiomed.2017.04.365] [PMID: 28457936]
[63]
Zhou B, Li Q, Wang J, Chen P, Jiang S. Ellagic acid attenuates streptozocin induced diabetic nephropathy via the regulation of oxidative stress and inflammatory signaling. Food Chem Toxicol 2019; 123: 16-27.
[http://dx.doi.org/10.1016/j.fct.2018.10.036] [PMID: 30342113]
[64]
Zhang J, Yang S, Li H, Chen F, Shi J. Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4. Eur J Pharmacol 2017; 804: 1-6.
[http://dx.doi.org/10.1016/j.ejphar.2017.04.006] [PMID: 28395989]
[65]
Lu M, Yin N, Liu W, Cui X, Chen S, Wang E. Curcumin ameliorates diabetic nephropathy by suppressing NLRP3 inflammasome signaling. BioMed Res Int 2017; 2017: 1-10.
[http://dx.doi.org/10.1155/2017/1516985] [PMID: 28194406]
[66]
Li X, Zhu Q, Zheng R, et al. Puerarin attenuates diabetic nephropathy by promoting autophagy in podocytes. Front Physiol 2020; 11: 73.
[http://dx.doi.org/10.3389/fphys.2020.00073] [PMID: 32116781]
[67]
Ma L, Wu F, Shao Q, Chen G, Xu L, Lu F. Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway. Drug Des Devel Ther 2021; 15: 3207-21.
[http://dx.doi.org/10.2147/DDDT.S319260] [PMID: 34321869]
[68]
Barhoma RAE. The role of eugenol in the prevention of chromium-induced acute kidney injury in male albino rats. Alex J Med 2018; 54(4): 711-5.
[http://dx.doi.org/10.1016/j.ajme.2018.05.006]
[69]
Sharma E, Behl T, Sachdeva M, Makkar R, Arora S. Protective role of herbal drugs in diabetic neuropathy: An updated review. J Pharm Technol Res 2018; 6(1): 21-31.
[http://dx.doi.org/10.15415/jptrm.2018.61003]
[70]
Wang P, Wen C, Olatunji OJ. Anti-inflammatory and antinociceptive effects of boesenbergia rotunda polyphenol extract in diabetic peripheral neuropathic rats. J Pain Res 2022; 15: 779-88.
[http://dx.doi.org/10.2147/JPR.S359766] [PMID: 35356266]
[71]
Alammar N, Wang L, Saberi B, et al. The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data. BMC Complement Altern Med 2019; 19(1): 21.
[http://dx.doi.org/10.1186/s12906-018-2409-0] [PMID: 30654773]
[72]
Karaman T, Karaman S, Dogru S, et al. Evaluating the efficacy of lavender aromatherapy on peripheral venous cannulation pain and anxiety: A prospective, randomized study. Complement Ther Clin Pract 2016; 23: 64-8.
[http://dx.doi.org/10.1016/j.ctcp.2016.03.008] [PMID: 27157961]
[73]
Salamati A, Mashouf S, Sahbaei F, Mojab F. Effects of inhalation of lavender essential oil on open-heart surgery pain. Iran J Pharm Res 2014; 13(4): 1257-61.
[PMID: 25587315]
[74]
Assiri K, Alyami Y, Uyanik JM, Romero-Reyes M. Hypericum perforatum (St. John’s Wort) as a possible therapeutic alternative for the management of trigeminal neuralgia (TN) – A case report. Complement Ther Med 2017; 30: 36-9.
[http://dx.doi.org/10.1016/j.ctim.2016.10.014] [PMID: 28137525]
[75]
Jiang J, Shen YY, Li J, Lin YH, Luo CX, Zhu DY. (+)-Borneol alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice. Eur J Pharmacol 2015; 757: 53-8.
[http://dx.doi.org/10.1016/j.ejphar.2015.03.056] [PMID: 25835611]
[76]
Sritoomma N, Moyle W, Cooke M, O’Dwyer S. The effectiveness of Swedish massage with aromatic ginger oil in treating chronic low back pain in older adults: A randomized controlled trial. Complement Ther Med 2014; 22(1): 26-33.
[http://dx.doi.org/10.1016/j.ctim.2013.11.002] [PMID: 24559813]
[77]
Grover JK, Rathi SS, Vats V. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. Indian J Exp Biol 2002; 40(3): 273-6.
[PMID: 12635695]
[78]
Malik ZA, Tabassum N, Sharma PL. Attenuation of experimentally induced diabetic neuropathy in association with reduced oxidative-nitrosative stress by chronic administration of Momordica charantia. Adv Biosci Biotechnol 2013; 4(3): 356-63.
[http://dx.doi.org/10.4236/abb.2013.43047]
[79]
Ferreira PEB, Lopes CR, Alves AM, et al. Diabetic neuropathy: An evaluation of the use of quercetin in the cecum of rats. World J Gastroenterol 2013; 19(38): 6416-26.
[http://dx.doi.org/10.3748/wjg.v19.i38.6416] [PMID: 24151360]
[80]
Oh Y. Bioactive compounds and their neuroprotective effects in diabetic complications. Nutrients 2016; 8(8): 472.
[http://dx.doi.org/10.3390/nu8080472] [PMID: 27483315]
[81]
Pearson J, Brandeis L, Cuello AC. Depletion of substance P-containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 1982; 295(5844): 61-3.
[http://dx.doi.org/10.1038/295061a0] [PMID: 6173753]
[82]
Buck SH, Burks TF. The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 1986; 38(3): 179-226.
[PMID: 3534898]
[83]
Baranowski R, Lynn B, Pini A. The effects of locally applied capsaicin on conduction in cutaneous nerves in four mammalian species. Br J Pharmacol 1986; 89(2): 267-76.
[http://dx.doi.org/10.1111/j.1476-5381.1986.tb10256.x] [PMID: 3779210]
[84]
Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 2006; 536(3): 256-61.
[http://dx.doi.org/10.1016/j.ejphar.2006.03.006] [PMID: 16584726]
[85]
Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets 2011; 12(3): 332-47.
[http://dx.doi.org/10.2174/138945011794815356] [PMID: 20955148]
[86]
Visnagri A, Kandhare AD, Chakravarty S, Ghosh P, Bodhankar SL. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm Biol 2014; 52(7): 814-28.
[http://dx.doi.org/10.3109/13880209.2013.870584] [PMID: 24559476]
[87]
Singh N, Hamid K, Goel Y, Singh L, Pandey RK. A review on diabetic neuropathy (DN): Classification, Diagnosis, Management, and its treatments. 2022; 20(15): 3519-8.
[http://dx.doi.org/10.14704/NQ.2022.20.15.NQ88347]

Rights & Permissions Print Cite
Article Metrics
55
2
Wayfinder Image
© 2026 Bentham Science Publishers | Privacy Policy